Infectious Problems of the Foot in Diabetic Patients

Levin and O'Neal's: The Diabetic Foot

Volumn , Issue , 2008, Pages 305-318

  Lipsky, Benjamin A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 52149093567     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-04145-4.50021-1     Document Type: Chapter

References (113)

1. Boyko EJ, Lipsky BA Infection and diabetes mellitus. Diabetes in America 1995, 485-499. National Institutes of Health, Bethesda, MD, NIH publication No 95-1468. 2nd ed. M.I. Harris (Ed.).
2. Gleckman RA, Al-Wawi M A review of selective infections in the adult diabetic. Compr Ther 1999, 25:109-113.
3. Jackson LA Evaluating diabetes mellitus as a risk factor for community-acquired infections. Clin Infect Dis 2005, 41(3):289-290.
4. Muller LM, Gorter KJ, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005, 41(3):281-288.
5. Shah BR, Hux JE Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003, 26(2):510-513.
6. Cavanagh PR, Buse JB, Frykberg RG, for the American Diabetes Association, et al. Diabetic foot wound care. Census Development Conference. Diabetes Care 1999, 22:1354-1360.
7. Fong IW, for the Committee on Antimicrobial Agents Management of diabetic foot infection: A position paper. Can J Infect Dis 1996, 7:361-365.
8. International Working Group on the Diabetic Foot: International Consensus on the Diabetic Foot. Amsterdam, May 1999, pp 1-96.
9. Lipsky BA A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab Res Rev 2004, 20(suppl 1):S68-S77.
10. Lipsky BA, Berendt AR, et al. IDSA Guidelines: Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004, 39:885-910.
11. Frykberg RG A summary of guidelines for managing the diabetic foot. Adv Skin Wound Care 2005, 18(4):209-214.
12. Pinzur MS, Slovenkai MP, et al. Guidelines for diabetic foot care: Recommendations endorsed by the Diabetes Committee of the American Orthopaedic Foot and Ankle Society. Foot Ankle Int 2005, 26(1):113-119.
13. Lavery LA, Armstrong DG, Wunderlich RP, et al. Risk factors for foot infection in persons with diabetes. Diabetes Care 2006, 6:1288-1293.
14. Peters EJ, Lavery LA, et al. Diabetic lower extremity infection: Influence of physical, psychological, and social factors. J Diabetes Complications 2005, 19(2):107-112.
15. Pecoraro RE, Ahroni JH, Boyko EJ, Stencil VL Chronology and determinants of tissue repair in diabetic lower-extremity ulcers. Diabetes 1991, 40:1305-1313.
16. Reiber GE, Pecoraro RE, Koepsell TD Risk factors for amputation in patients with diabetes mellitus: A case control study. Ann Intern Med 1992, 117:97-105.
17. Bowler PG Wound pathophysiology, infection and therapeutic options. Ann Med 2002, 34(6):419-427.
18. Levin M Diabetic foot wounds: Pathogenesis and management. Adv Wound Care 1997, 10(2):24-30.
19. McMahon MM, Bistrian BR Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 1995, 9:1-10.
20. Sentochnik DE, Eliopoulos GM Infection and diabetes. Joslin's Diabetes Mellitus 1994, 867-888. Lea & Febiger, Philadelphia. 13th ed. C.R. Kahn, G.C. Weir (Eds.).
21. Breen JD, Karchmer AW Staphylococcus aureus infections in diabetic patients. Infect Dis Clin North Am 1995, 9:11-24.
22. Mayser P, Hensel J, et al. Prevalence of fungal foot infections in patients with diabetes mellitus type 1: Underestimation of moccasin-type tinea. Exp Clin Endocrinol Diabetes 2004, 112(5):264-268.
23. Rauwerda JA Foot debridement: anatomic knowledge is mandatory. Diabetes Metab Res Rev 2000, 16(suppl 1):S23-S26.
24. Armstrong DG, Lipsky BA Advances in the treatment of diabetic foot infections. Diabetes Technol Ther 2004, 6(2):167-177.
25. van Baal JG Surgical treatment of the infected diabetic foot. Clin Infect Dis 2004, 39(suppl 2):S123-S128.
26. Bridges RM, Deitch EA Diabetic foot infections: Pathophysiology and treatment. Surg Clin North Am 1994, 74:537-555.
27. Bowler PG The 10(5) bacterial growth guideline: Reassessing its clinical relevance in wound healing. Ostomy Wound Manage 2003, 49(1):44-53.
28. Lipsky BA, Pecoraro RE, Larson SA, Ahroni JH Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch Intern Med 1990, 150:790-797.
29. Lipsky BA, Pecoraro RE, Wheat JL The diabetic foot: Soft tissue and bone infection. Infect Dis Clin North Am 1990, 4:409-432.
30. Bowler PG, Duerden BI, et al. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001, 14(2):244-269.
31. Tan JS, Joseph WS Common fungal infections of the feet in patients with diabetes mellitus. Drugs Aging 2004, 21(2):101-112.
32. Wheat LJ, Allen SD, Henry M, et al. Diabetic foot infections: Bacteriologic analysis. Arch Intern Med 1986, 146:1935-1940.
33. Pellizzer G, Strazzabosco M, et al. Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabet Med 2001, 18(10):822-827.
34. Sapico FL, Witte JL, Canawati HN, et al. The infected foot of the diabetic patient: Quantitative microbiology and analysis of clinical features. Rev Infect Dis 1984, 6(suppl 1):171-176.
35. Lipsky BA, Armstrong DG, et al. Ertapenem versus piperacillin/ tazobactam for diabetic foot infections (SIDESTEP): Prospective, randomised, controlled, double-blinded, multicentre trial.". Lancet 2005, 366(9498):1695-1703.
36. Dang CN, Prasad YD, et al. Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: A worsening problem. Diabet Med 2003, 20(2):159-161.
37. Eady EA, Cove JH Staphylococcal resistance revisited: Community-acquired methicillin resistant Staphylococcus aureus-An emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis 2003, 16(2):103-124.
38. Tentolouris N, Petrikkos G, et al. Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect 2006, 12(2):186-189.
39. Williams DT, Hilton JR, et al. Diagnosing foot infection in diabetes. Clin Infect Dis 2004, 39(suppl 2):S83-S836.
40. Pakarinen TK, Laine HJ, et al. Charcot arthropathy of the diabetic foot: Current concepts and review of 36 cases. Scand J Surg 2002, 91(2):195-201.
41. Newman LG, Waller J, Palestro CJ, et al. Unsuspected osteomyelitis in diabetic foot ulcers: Diagnosis and monitoring by leukocyte scanning with indium 111 oxyquinoline. JAMA 1991, 266:1246-1251.
42. Eneroth M, Apelqvist J, Stenstrom A Clinical characteristics and outcome in 223 diabetic patients with deep foot infections. Foot Ankle Int 1997, 18:716-722.
43. Armstrong DG, Lavery LA, et al. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg 1996, 35(4):280-283.
44. Edelson GW, Armstrong DG, Lavery LA, Caicco G The acutely infected diabetic foot is not adequately evaluated in an inpatient setting. Arch Intern Med 1996, 156:2373-2378.
45. Armstrong DG, Perales TA, Murff RT, et al. Value of white blood cell count with differential in the acute diabetic foot infection. J Am Podiatr Med Assoc 1996, 86:224-227.
46. Pecoraro RE Diabetic skin ulcer classification for clinical investigations. Clin Mater 1991, 8:257-262.
47. Foster A, Edmonds ME Simple staging system: A tool for diagnosis and management. Diabetic Foot 2000, 3(2):56-62.
48. Armstrong DG, Lavery LA, Harkless LB Validation of a diabetic wound classification system: The contribution of depth, infection, and ischemia to risk of amputation. Diabet Med 1998, 21:855-859.
49. Oyibo SO, Jude EB, et al. A comparison of two diabetic foot ulcer classification systems: The Wagner and the University of Texas wound classification systems. Diabetes Care 2001, 24(1):84-88.
50. Snyder RJ, Cohen MM, et al. Osteomyelitis in the diabetic patient: Diagnosis and treatment. Part 1: Overview, diagnosis, and microbiology. Ostomy Wound Manage 2001, 47(1):18-22. 25-30; quiz 31-32,.
51. Snyder RJ, Cohen MM, et al. Osteomyelitis in the diabetic patient: Diagnosis and treatment. Part 2: Medical, surgical, and alternative treatments. Ostomy Wound Manage 2001, 47(3):24-30. 32-41; quiz 42-43,.
52. Rajbhandari SM, Sutton M, et al. "Sausage toe": A reliable sign of underlying osteomyelitis. Diabet Med 2000, 17(1):74-77.
53. Kaleta JL, Fleischli JW, et al. The diagnosis of osteomyelitis in diabetes using erythrocyte sedimentation rate: A pilot study. J Am Podiatr Med Assoc 2001, 91(9):445-450.
54. Karr JC The diagnosis of osteomyelitis in diabetes using erythrocyte sedimentation rate. J Am Podiatr Med Assoc 2002, 92(5):314. author reply 314-315,.
55. Grayson ML, Gibbons GW, Balogh K, et al. Probing to bone in infected pedal ulcers: A clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995, 273:721-723.
56. Sella EJ, Grosser DM Imaging modalities of the diabetic foot. Clin Podiatr Med Surg 2003, 20(4):729-740.
57. Newman LG Imaging techniques in the diabetic foot. Clin Podiatr Med Surg 1995, 12(1):75-86.
58. Bonham P A critical review of the literature: I. Diagnosing osteomyelitis in patients with diabetes and foot ulcers. J Wound Ostomy Continence Nurs 2001, 28(2):73-88.
59. Lipsky BA Osteomyelitis of the foot in diabetic patients. Clin Infect Dis 1997, 25:1318-1326.
60. Wrobel JS, Connolly JE Making the diagnosis of osteomyelitis: The role of prevalence. J Am Podiatr Med Assoc 1998, 88:337-343.
61. Harwood SJ, Valdivia S, Hung G-L, Quenzer RW Use of sulesomab, a radiolabeled antibody fragment, to detect osteomyelitis in diabetic patients with foot ulcers by leukoscintigraphy. Clin Infect Dis 1999, 28:1200-1205.
62. Sarikaya A, Aygit AC, et al. Utility of 99m Tc dextran scintigraphy in diabetic patients with suspected osteomyelitis of the foot. Ann Nucl Med 2003, 17(8):669-676.
63. Keidar Z, Militianu D, et al. The diabetic foot: Initial experience with 18F-FDG PET/CT. J Nucl Med 2005, 46(3):444-449.
64. Craig JG, Amin MB, Wu K, et al. Osteomyelitis of the diabetic foot: MR imaging-pathological correlation. Radiology 1997, 203:849-855.
65. Schweitzer ME, Morrison WB MR imaging of the diabetic foot. Radiol Clin North Am 2004, 42(1):61-71. vi.
66. Chatha DS, Cunningham PM, et al. MR imaging of the diabetic foot: Diagnostic challenges. Radiol Clin North Am 2005, 43(4):747-759. ix,.
67. Khatri G, Wagner DK, et al. Effect of bone biopsy in guiding antimicrobial therapy for osteomyelitis complicating open wounds. Am J Med Sci 2001, 321(6):367-371.
68. Zuluaga AF, Galvis W, et al. Lack of microbiological concordance between bone and non-bone specimens in chronic osteomyelitis: An observational study. BMC Infect Dis 2002, 2(1):8.
69. Kessler L, Piemont Y, et al. Comparison of microbiological results of needle puncture vs. superficial swab in infected diabetic foot ulcer with osteomyelitis. Diabet Med 2006, 23(1):99-102.
70. Senneville E, Melliez H, et al. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: Concordance with ulcer swab cultures. Clin Infect Dis 2006, 42(1):57-62.
71. Zuluaga AF, Galvis W, et al. Etiologic diagnosis of chronic osteomyelitis: A prospective study. Arch Intern Med 2006, 166(1):95-100.
72. Jones V Debridement of diabetic foot lesions. Diabet Foot 1998, 3:88-94.
73. Smith J, Thow J Update of systematic review on debridement. Diabetic Foot 2003, 6(1):12-16.
74. Armstrong DG, Mossel J, et al. Maggot debridement therapy: A primer. J Am Podiatr Med Assoc 2002, 92(7):398-401.
75. Claxton MJ, Armstrong DG, et al. 5 questions-and answers- about maggot debridement therapy. Adv Skin Wound Care 2003, 16(2):99-102.
76. Armstrong DG, Salas P, et al. Maggot therapy in "lower-extremity hospice" wound care: Fewer amputations and more antibiotic-free days. J Am Podiatr Med Assoc 2005, 95(3):254-257.
77. Tan JS, Friedman NM, Hazelton-Miller C, et al. Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation?. Clin Infect Dis 1996, 23:286-291.
78. Gibbons GW, Habershaw GM Diabetic foot infections: Anatomy and surgery. Infect Dis Clin North Am 1995, 9:131-142.
79. Pinzur MS, Pinto MA, et al. Controversies in amputation surgery. Instr Course Lect 2003, 52:445-451.
80. Nelson EA, O'Meara S, Golder S, et al: Systematic review of antimicrobial treatments for diabetic foot ulcers. Diabet Med (in press), 2006.
81. Jaegeblad G, Apelqvist J, Nyberg P, Berger B: The diabetic foot: From ulcer to multidisciplinary team approach. A process analysis. In Abstracts of the 3rd International Symposium of the Diabetic Foot, Noordwijkerhout, The Netherlands, May 6, 1998, Abstract p87, p 149.
82. Chantelau E, Tanudjaja T, Altenhöfer F, et al. Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: A controlled trial. Diabet Med 1996, 13:156-159.
83. Edmonds M, Foster A The use of antibiotics in the diabetic foot. Am J Surg 2004, 187(5A):25S-28S.
84. Tice A, Hoaglund P, et al. Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy. Am J Med 2003, 114(9):723-728.
85. Raymakers JT, Houben AJ, et al. The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb [online abstract & ms]. Diabetic Medicine 2001, 18(3):229-234.
86. Legat FJ, Maier A, et al. Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome. Antimicrob Agents Chemother 2003, 47(1):371-374.
87. Oberdorfer K, Swoboda S, et al. Tissue and serum levofloxacin concentrations in diabetic foot infection patients. J Antimicrob Chemother 2004, 54(4):836-839.
88. Armstrong DG, Stephan KT, et al. What is the shelf-life of physician-mixed antibiotic-impregnated calcium sulfate pellets?. J Foot Ankle Surg 2003, 42(5):302-304.
89. Greenberg RN, Newman MT, et al. Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis. Antimicrob Agents Chemother 2000, 44(1):164-166.
90. Edmiston CE, Krepel CJ, et al. In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections. Antimicrob Agents Chemother 2004, 48(3):1012-1016.
91. Lipsky BA, Itani K, et al. Treating foot infections in diabetic patients: A randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate. Clin Infect Dis 2004, 38(1):17-24.
92. Sibbald RG Topical antimicrobials. Ostomy Wound Manage 2003, 49(5A suppl):14-18.
93. Bergin S, Wraight P Silver based wound dressings and topical agents for treating diabetic foot ulcers. Cochrane Database Syst Rev 2006, 1:CD005082.
94. Lipsky BA, McDonald D, Litka PA Treatment of infected diabetic foot ulcers: Topical MSI-78 vs. oral ofloxacin [abstract]. Diabetologia 1997, 40(suppl 1):482.
95. Ragnarson Tennvall G, Apelqvist J, Eneroth M: Costs of deep foot infections: An analysis of factors determining treatment costs. Abstracts of the 3rd International Symposium of the Diabetic Foot. Noordwijkerhout, The Netherlands, May 5-8, 1999, Abstract p 101, p 163.
96. McKinnon PS, Paladino JA, Grayson ML, et al. Cost effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clin Infect Dis 1997, 24:57-63.
97. Senneville E Antimicrobial interventions for the management of diabetic foot infections. Expert Opin Pharmacother 2005, 6(2):263-273.
98. Lazzarini L, Lipsky BA, et al. Antibiotic treatment of osteomyelitis: What have we learned from 30 years of clinical trials?. Int J Infect Dis 2005, 9(3):127-138.
99. Pittet D, Wyssa B, Herter-Clavel C, et al. Outcome of diabetic foot infections treated conservatively: A retrospective cohort study with long-term follow-up. Arch Intern Med 1999, 159:851-856.
100. Venkatesan P, Lawn S, Macfarlane RM, et al. Conservative management of osteomyelitis in the feet of diabetic patients. Diabetic Med 1997, 14:487-490.
101. Jeffcoate WJ, Lipsky BA Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin Infect Dis 2004, 39(suppl 2):S115-S122.
102. Henke PK, Blackburn SA, et al. Osteomyelitis of the foot and toe in adults is a surgical disease: Conservative management worsens lower extremity salvage. Ann Surg 2005, 241(6):885-892. discussion 892-894,.
103. Salvana J, Rodner C, et al. Chronic osteomyelitis: Results obtained by an integrated team approach to management. Conn Med 2005, 69(4):195-202.
104. Cruciani M, Lipsky BA, et al. Are granulocyte colony-stimulating factors beneficial in treating diabetic foot infections?: A metaanalysis. Diabetes Care 2005, 28(2):454-460.
105. Chen CE, Shih ST, et al. Hyperbaric oxygen therapy in the treatment of chronic refractory osteomyelitis: A preliminary report. Chang Gung Med J 2003, 26(2):114-121.
106. Stone JA, Cianci P The adjunctive role of hyperbaric oxygen in the treatment of lower extremity wounds in patients with diabetes. Diabetes Spectrum 1997, 10:118-123.
107. Kranke P, Bennett M, et al. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2004, 2:CD004123.
108. Caputo GM, Cavanaugh PR, Ulbrecht JS, et al. Assessment and management of foot disease in patients with diabetes. N Engl J Med 1994, 331:854-860.
109. Sumpio BE, Lee T, et al. Vascular evaluation and arterial reconstruction of the diabetic foot. Clin Podiatr Med Surg 2003, 20(4):689-708.
110. Akbari CM, Pomposelli FB, et al. Lower extremity revascularization in diabetes: late observations. Arch Surg 2000, 135(4):452-456.
111. Van Damme H, Rorive M, et al. Amputations in diabetic patients: A plea for footsparing surgery. Acta Chir Belg 2001, 101(3):123-129.
112. Rauwerda JA Surgical treatment of the infected diabetic foot. Diabetes Metab Res Rev 2004, 20(suppl 1):S41-S44.
113. Eneroth M, Larsson J, Apelqvist J Deep foot infection in diabetes mellitus: An entity with different characteristics, treatment and prognosis. J Diabetic Complications 1999, 13:254-263.